Quick Answer
Edesa Biotech, Inc. reported Stockholders Equity of $12.45 million for fiscal year 2025.
Edesa Biotech, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $12.45M | +528.5% |
| 2024 | $1.98M | -71.9% |
| 2023 | $7.05M | -24.9% |
| 2022 | $9.39M | -28.1% |
| 2021 | $13.06M | +96.9% |
| 2020 | $6.63M | +26.2% |
| 2019 | $5.26M | +63.5% |
| 2018 | $3.21M | -71.5% |
| 2018 | $11.29M | +52.5% |
| 2017 | $7.40M | -39.9% |
| 2016 | $12.31M | +53.8% |
| 2015 | $8.01M | -23.5% |
| 2014 | $10.46M | +35.9% |
| 2014 | $7.70M | +450.7% |
| 2013 | -$2.20M | -343.4% |
| 2012 | $902.2K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $13.95M | +516.4% | +12.1% |
| September 30, 2025 | $12.45M | +528.5% | -11.9% |
| June 30, 2025 | $14.13M | +392.9% | -9.1% |
| March 31, 2025 | $15.54M | +259.4% | +586.4% |
| December 31, 2024 | $2.26M | -61.3% | +14.3% |
| September 30, 2024 | $1.98M | -71.9% | -30.9% |
| June 30, 2024 | $2.87M | -63.5% | -33.7% |
| March 31, 2024 | $4.32M | -52.0% | -26.0% |
- Edesa Biotech, Inc. showed an increase of +528.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2012–2025 period, Edesa Biotech, Inc.’s stockholders equity has grown by 1280.2% (from $902.2 thousand to $12.45 million).
- The most recent figure is from Edesa Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 12, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: